The/DT
OAuth/NN
2.0/CD
Web/NN
Authorization/NN
Protocol/JJ
for/IN
the/DT
Internet/NN
Addiction/NN
Bioinformatics/NNS
(/(
IABio/NN
)/)
Database/NN
./.
====================
Internet/RB
addiction/NN
(/(
IA/NN
)/)
has/VBZ
become/VBN
a/DT
widespread/JJ
and/CC
problematic/JJ
phenomenon/NN
as/IN
smart/JJ
devices/VBZ
pervade/NN
society/NN
./.
====================
Moreover/RB
,/,
internet/JJ
gaming/VBG
disorder/NN
leads/VBZ
to/TO
increases/VBZ
in/IN
social/JJ
expenditures/VBZ
for/IN
both/DT
individuals/NNS
and/CC
nations/NNS
alike/RB
./.
====================
Although/IN
the/DT
prevention/NN
and/CC
treatment/NN
of/IN
IA/NN
are/VBP
getting/VBG
more/RBR
important/JJ
,/,
the/DT
diagnosis/NN
of/IN
IA/NN
remains/VBZ
problematic/JJ
./.
====================
Understanding/VBG
the/DT
neurobiological/JJ
mechanism/NN
of/IN
behavioral/JJ
addictions/NNS
is/VBZ
essential/JJ
for/IN
the/DT
development/NN
of/IN
specific/JJ
and/CC
effective/JJ
treatments/NNS
./.
====================
Although/IN
there/EX
are/VBP
many/JJ
databases/NNS
related/JJ
to/TO
other/JJ
addictions/NNS
,/,
a/DT
database/NN
for/IN
IA/NN
has/VBZ
not/RB
been/VBN
developed/VBN
yet/RB
./.
====================
In/IN
addition/NN
,/,
bioinformatics/NNS
databases/NNS
,/,
especially/RB
genetic/JJ
databases/NNS
,/,
require/VBP
a/DT
high/JJ
level/NN
of/IN
security/NN
and/CC
should/MD
be/VB
designed/VBN
based/VBN
on/IN
medical/JJ
information/NN
standards/IN
./.
====================
In/IN
this/DT
respect/NN
,/,
our/PRP$
study/NN
proposes/VBZ
the/DT
OAuth/NN
standard/JJ
protocol/NN
for/IN
database/NN
access/VBP
authorization/NN
./.
====================
The/DT
proposed/JJ
IA/NN
Bioinformatics/NNS
(/(
IABio/NN
)/)
database/NN
system/NN
is/VBZ
based/VBN
on/IN
internet/JJ
user/NN
authentication/NN
,/,
which/WDT
is/VBZ
a/DT
guideline/NN
for/IN
medical/JJ
information/NN
standards/IN
,/,
and/CC
uses/VBZ
OAuth/NN
2.0/CD
for/IN
access/RB
control/NN
technology/NN
./.
====================
This/DT
study/NN
designed/VBD
and/CC
developed/VBD
the/DT
system/NN
requirements/NNS
and/CC
configuration/NN
./.
====================
The/DT
OAuth/NN
2.0/CD
protocol/NN
is/VBZ
expected/VBN
to/TO
establish/VB
the/DT
security/NN
of/IN
personal/JJ
medical/JJ
information/NN
and/CC
be/VB
applied/VBN
to/TO
genomic/JJ
research/NN
on/IN
IA/NN
./.
====================
Information/NN
technology/NN
has/VBZ
developed/VBN
so/RB
rapidly/RB
all/DT
over/IN
the/DT
world/NN
that/DT
smart/VBP
devices/VBZ
have/VBP
become/VBN
popularized/VBN
and/CC
digital/JJ
contents/NNS
have/VBP
been/VBN
diversified/VBN
./.
====================
As/IN
a/DT
consequence/NN
,/,
internet/JJ
addiction/NN
(/(
IA/NN
)/)
has/VBZ
become/VBN
an/DT
important/JJ
issue/NN
./.
====================
Although/IN
the/DT
prevention/NN
and/CC
treatment/NN
of/IN
IA/NN
are/VBP
more/RBR
important/JJ
than/IN
ever/RB
due/JJ
to/TO
pervasive/JJ
digital/JJ
media/NNS
and/CC
although/IN
measures/NNS
to/TO
establish/VB
a/DT
systematic/JJ
research/NN
environment/NN
and/CC
overcome/VBP
addiction/NN
problems/VBZ
are/VBP
more/RBR
necessary/JJ
than/IN
ever/RB
,/,
unfortunately/RB
,/,
these/DT
steps/NNS
not/RB
progressing/VBG
fast/JJ
enough/IN
./.
====================
It/PRP
has/VBZ
been/VBN
known/VBN
that/IN
IA/NN
leads/VBZ
to/TO
diverse/JJ
psychosomatic/JJ
problems/NNS
,/,
such/JJ
as/IN
nonaggressive/JJ
or/CC
oppositional/JJ
behavior/NN
and/CC
hostility/NN
./.
====================
In/IN
Korea/NN
,/,
it/PRP
was/VBD
reported/VBN
that/IN
7/CD
%/NN
of/IN
internet/JJ
users/NNS
aged/JJ
5/CD
to/TO
54/CD
years/NNS
are/VBP
at/IN
risk/NN
of/IN
IA/NN
,/,
and/CC
the/DT
percentage/NN
keeps/NNS
growing/VBG
[/(
1/CD
]/)
./.
====================
IA/NN
disorder/NN
,/,
which/WDT
has/VBZ
many/JJ
similarities/NNS
to/TO
psychopathological/JJ
disorders/NNS
,/,
is/VBZ
on/IN
the/DT
rise/NN
and/CC
is/VBZ
considered/VBN
a/DT
potential/JJ
problem/NN
./.
====================
Therefore/RB
,/,
a/DT
diagnostic/JJ
standard/JJ
is/VBZ
required/VBN
considering/VBG
DNA/NN
,/,
protein/NN
,/,
and/CC
the/DT
characteristics/NNS
of/IN
the/DT
structure/NN
of/IN
the/DT
brain/NN
./.
====================
Many/JJ
studies/NNS
have/VBP
been/VBN
conducted/VBN
on/IN
genomes/NNS
that/IN
affect/VBP
addictions/NNS
to/TO
substances/NNS
,/,
such/JJ
as/IN
alcohol/NN
,/,
and/CC
a/DT
considerable/JJ
number/NN
of/IN
databases/NNS
have/VBP
been/VBN
built/JJ
up/IN
./.
====================
However/RB
,/,
a/DT
biological/JJ
database/NN
of/IN
genes/NNS
,/,
proteins/NNS
,/,
and/CC
brain/NN
structures/NNS
,/,
which/WDT
can/MD
be/VB
used/VBN
directly/RB
for/IN
IA/NN
,/,
is/VBZ
not/RB
sufficient/JJ
./.
====================
To/TO
build/JJ
a/DT
genome/NN
database/NN
related/JJ
to/TO
IA/NN
,/,
personal/JJ
genome/NN
data/NNS
,/,
which/WDT
are/VBP
sensitive/JJ
to/TO
handle/VB
,/,
have/VBP
to/TO
be/VB
examined/VBN
,/,
so/RB
security/NN
should/MD
be/VB
guaranteed/JJ
./.
====================
In/IN
addition/NN
,/,
a/DT
medical/JJ
information/NN
standard-based/VBD
environment/NN
is/VBZ
very/RB
important/JJ
in/IN
terms/NNS
of/IN
security/NN
./.
====================
It/PRP
requires/VBZ
a/DT
medical/JJ
information/NN
standard/JJ
and/CC
access/VBP
control/NN
technology/NN
for/IN
the/DT
service/NN
environment/NN
of/IN
genomic/JJ
database/NN
[/(
23/CD
]/)
./.
====================
Integration/NN
in/IN
the/DT
Healthcare/JJ
Enterprise/NN
(/(
IHE/NN
)/)
[/(
4/CD
]/)
is/VBZ
providing/VBG
various/JJ
types/NNS
of/IN
standard/JJ
guidelines/NNS
to/TO
control/VB
access/RB
to/TO
medical/JJ
information/NN
./.
====================
IHE/NN
access/VBP
control/NN
guidelines/NNS
include/VBP
cross-domain/NN
user/NN
authentication/NN
(/(
XUA/NN
)/)
,/,
enterprise/VBP
user/NN
authentication/NN
(/(
EUA/NN
)/)
and/CC
internet/JJ
user/NN
authentication/NN
(/(
IUA/NN
)/)
[/(
5/CD
]/)
./.
====================
IUA/NN
provides/VBZ
the/DT
guidelines/NNS
for/IN
access/NN
to/TO
OAuth/NN
2.0-based/VBN
medical/JJ
information/NN
service/VBP
./.
====================
OAuth/DT
2.0/CD
[/(
6/CD
]/)
is/VBZ
an/DT
access/NN
control/NN
method/NN
that/DT
manages/VBZ
several/JJ
services/NNS
in/IN
a/DT
group/NN
with/IN
one/CD
integrated/VBN
ID/NN
./.
====================
It/PRP
is/VBZ
used/VBN
by/IN
Google/JJ
and/CC
Facebook/NN
./.
====================
Therefore/RB
,/,
it/PRP
provides/VBZ
easy/RB
scalability/NN
into/IN
medical/JJ
systems/NNS
and/CC
easy/RB
control/NN
of/IN
authority/NN
for/IN
access/NN
[/(
7/CD
]/)
./.
====================
In/IN
this/DT
paper/NN
,/,
we/PRP
propose/VBP
the/DT
medical/JJ
standard-based/VBD
IA/NN
Bioinformatics/NNS
(/(
IABio/NNP
)/)
database/NN
platform/NN
service/RB
,/,
which/WDT
can/MD
integrate/VB
the/DT
data/NNS
on/IN
genes/NNS
,/,
proteins/NNS
,/,
and/CC
brain/NN
structure/NN
image/NN
data/NNS
in/IN
internet/JJ
and/CC
game/JJ
addiction/NN
into/IN
one/CD
database/NN
./.
====================
IABio/NN
follows/VBZ
medical/JJ
standard-based/VBD
guidelines/NNS
and/CC
controls/VBZ
access/VBP
to/TO
database/NN
using/VBG
OAuth/NN
2.0/CD
./.
====================
Therefore/RB
,/,
using/VBG
IABio/JJ
can/MD
provide/VB
a/DT
medical/JJ
standard-based/VBD
service/RB
environment/NN
and/CC
will/MD
allow/VB
various/JJ
integrated/JJ
research/NN
studies/NNS
with/IN
an/DT
access/NN
control/NN
method/NN
that/DT
enables/VBZ
interchange/NN
with/IN
other/JJ
clinical/JJ
data/NNS
./.
====================
The/DT
present/JJ
study/NN
is/VBZ
composed/VBN
as/IN
follows/VBZ
./.
====================
Relevant/JJ
studies/NNS
and/CC
literature/NN
on/IN
this/DT
topic/JJ
are/VBP
described/VBN
in/IN
section/NN
II/CD
./.
====================
In/IN
section/NN
III/CD
,/,
IABio/NN
is/VBZ
designed/VBN
./.
====================
In/IN
section/NN
IV/CD
,/,
the/DT
designed/VBN
IABio/NN
is/VBZ
explained/VBN
./.
====================
Our/PRP$
study/NN
closes/VBZ
with/IN
conclusions/NNS
in/IN
section/NN
V/JJ
./.
====================
Addiction/NN
genome/NN
database/NN
====================
A/DT
genome/NN
database/NN
has/VBZ
many/JJ
merits/NNS
,/,
such/JJ
as/IN
predicting/VBG
the/DT
occurrence/NN
of/IN
disease/NN
and/CC
thus/RB
preventing/VBG
and/CC
swiftly/RB
diagnosing/VBG
it/PRP
,/,
which/WDT
leads/VBZ
to/TO
early/JJ
treatment/NN
;/:
determining/VBG
the/DT
prognosis/NN
accurately/RB
by/IN
selecting/VBG
the/DT
treatment/NN
of/IN
a/DT
certain/JJ
gene/NN
;/:
and/CC
evaluating/VBG
the/DT
effectiveness/NN
of/IN
treatment/NN
./.
====================
It/PRP
has/VBZ
been/VBN
difficult/JJ
to/TO
verify/VB
the/DT
connection/NN
between/IN
addiction/NN
and/CC
genes/NNS
in/IN
the/DT
past/NN
,/,
but/CC
some/DT
attempts/NNS
have/VBP
been/VBN
made/VBN
to/TO
identify/VB
the/DT
DNA/NN
responsible/JJ
for/IN
addiction/NN
in/IN
the/DT
last/JJ
decade/NN
./.
====================
The/DT
findings/NNS
say/RB
that/DT
when/WRB
a/DT
genetic/JJ
mutation/NN
occurs/VBZ
in/IN
a/DT
certain/JJ
region/NN
of/IN
dopamine/NN
receptor/NN
in/IN
a/DT
human/JJ
brain/NN
,/,
dopamine/NN
receptor/NN
fails/VBZ
to/TO
function/VB
properly/RB
and/CC
thus/RB
can/MD
have/VB
superficial/JJ
behavioral/JJ
inclinations/NNS
,/,
such/JJ
as/IN
addiction/NN
to/TO
smoking/VBG
,/,
alcohol/NN
,/,
or/CC
drugs/NNS
[/(
8/CD
]/)
./.
====================
According/VBG
to/TO
those/DT
studies/NNS
,/,
when/WRB
genetic/JJ
mutation/NN
occurs/VBZ
in/IN
a/DT
certain/JJ
region/NN
of/IN
dopamine/NN
receptor/NN
in/IN
a/DT
human/JJ
brain/NN
,/,
dopamine/NN
receptor/NN
fails/VBZ
to/TO
function/VB
properly/RB
,/,
and/CC
when/WRB
the/DT
mutated/VBN
genes/NNS
make/VBP
contact/NN
with/IN
a/DT
substance/NN
,/,
they/PRP
secrete/VBP
acetylcholine/NN
,/,
which/WDT
stimulates/VBZ
pleasure/NN
,/,
which/WDT
leads/VBZ
to/TO
addiction/NN
./.
====================
The/DT
genes/NNS
known/VBN
to/TO
be/VB
related/JJ
to/TO
addiction/NN
are/VBP
DRD2/NN
Tag/NN
1A/NN
,/,
DRD2/NN
Tag/NN
1B/NN
,/,
and/CC
so/RB
on/IN
./.
====================
A/DT
German/NNP
psychobiologic/JJ
research/NN
team/JJ
examined/VBN
and/CC
compared/VBD
132/CD
internet/JJ
addicts/VBZ
and/CC
711/CD
normal/JJ
people/JJ
to/TO
find/VB
the/DT
cause/JJ
of/IN
addiction/NN
and/CC
found/VBD
that/IN
most/JJS
of/IN
the/DT
addicts/NNS
had/VBD
a/DT
mutated/VBN
gene/NN
called/VBN
CHRNA4NA4/NN
[/(
9/CD
]/)
./.
====================
It/PRP
is/VBZ
necessary/JJ
that/DT
a/DT
database/NN
be/VB
built/JJ
for/IN
addiction/NN
and/CC
that/IN
a/DT
service/JJ
provision/NN
environment/NN
be/VB
established/VBN
for/IN
studies/NNS
regarding/VBG
IA/NN
./.
====================
Therefore/RB
,/,
an/DT
integrated/JJ
database/NN
is/VBZ
required/VBN
to/TO
support/VB
genome/NN
research/NN
and/CC
analysis/NN
./.
====================
IUA/OAuth/DT
2.0/CD
====================
Genes/NNS
,/,
proteins/NNS
,/,
and/CC
neuroimages/NNS
require/VBP
tight/JJ
security/NN
,/,
because/IN
they/PRP
are/VBP
very/RB
sensitive/JJ
information/NN
in/IN
terms/NNS
of/IN
personal/JJ
information/NN
privacy/NN
./.
====================
To/TO
use/VB
such/JJ
information/NN
,/,
medical/JJ
standards/NNS
should/MD
be/VB
complied/VBN
and/CC
proper/JJ
guidelines/NNS
should/MD
be/VB
used/VBN
./.
====================
Our/PRP$
study/NN
uses/VBZ
the/DT
IUA/NN
method/NN
by/IN
IHE/NN
,/,
which/WDT
provides/VBZ
medical/JJ
standard/JJ
guidelines/NNS
[/(
45/CD
]/)
./.
====================
IUA/NN
is/VBZ
an/DT
IHE/NN
profile/NN
based/VBN
on/IN
access/RB
control/NN
with/IN
token-based/VBN
authentication/NN
and/CC
provides/VBZ
access/VBP
authority/NN
to/TO
medical/JJ
information/NN
services/VBZ
and/CC
guidelines/NNS
for/IN
user/NN
authentication/NN
./.
====================
The/DT
IUA/NN
guideline/NN
is/VBZ
seen/VBN
in/IN
Fig/NN
./.
====================
1/CD
./.
====================
It/PRP
can/MD
grant/JJ
only/RB
necessary/JJ
authorities/NNS
to/TO
other/JJ
users/NNS
according/VBG
to/TO
database/NN
policy/NN
and/CC
can/MD
also/RB
provide/VBP
other/JJ
services/NNS
in/IN
a/DT
single/JJ
server/RB
,/,
which/WDT
means/NNS
that/DT
it/PRP
has/VBZ
an/DT
excellent/JJ
scalability/NN
./.
====================
In/IN
addition/NN
,/,
when/WRB
authorization/NN
is/VBZ
obtained/VBN
from/IN
one/CD
authorization/NN
server/RB
,/,
it/PRP
allows/VBZ
the/DT
authority/NN
to/TO
use/VB
the/DT
information/NN
related/JJ
to/TO
a/DT
certain/JJ
user/NN
./.
====================
For/IN
an/DT
authorization/NN
client/JJ
to/TO
use/VB
the/DT
resource/NN
,/,
it/PRP
is/VBZ
necessary/JJ
to/TO
obtain/VB
an/DT
authorization/NN
token/VBN
from/IN
the/DT
authorization/NN
server/RB
./.
====================
Authorization/NN
token/NN
holders/NNS
need/VBD
to/TO
check/VB
the/DT
terms/NNS
of/IN
validity/NN
before/IN
using/VBG
it/PRP
./.
====================
In/IN
case/NN
the/DT
term/NN
expires/NNS
,/,
they/PRP
need/VBD
to/TO
get/VB
new/JJ
authorization/NN
tokens/NNS
./.
====================
A/DT
database/NN
environment/NN
is/VBZ
suitable/JJ
for/IN
using/VBG
other/JJ
data/NNS
,/,
such/JJ
as/IN
genes/NNS
,/,
proteins/NNS
,/,
and/CC
brain/NN
images/VBZ
,/,
and/CC
can/MD
protect/VB
patients/NNS
'/``
data/NNS
systematically/RB
./.
====================
In/IN
this/DT
study/NN
,/,
IUA/NN
is/VBZ
used/VBN
to/TO
build/JJ
a/DT
database/NN
applied/VBN
with/IN
a/DT
medical/JJ
information/NN
standard/JJ
and/CC
OAuth/NN
2.0/CD
to/TO
be/VB
applied/VBN
to/TO
standard/JJ
IUA/NN
guidelines/NNS
./.
====================
OAuth/DT
2.0/CD
is/VBZ
a/DT
protocol/NN
with/IN
authorization/NN
function/NN
to/TO
control/VB
and/CC
manage/VBP
access/VBP
to/TO
web/NN
services/VBZ
./.
====================
The/DT
HTTP/NN
RESTful/JJ
method/NN
is/VBZ
used/VBN
to/TO
perform/VB
access/VBP
control/NN
using/VBG
an/DT
authorization/NN
token/VBN
and/CC
to/TO
ask/VB
an/DT
authorization/NN
server/RB
for/IN
resources/NNS
[/(
10/CD
]/)
./.
====================
HTTP/NN
RESTful/JJ
is/VBZ
a/DT
method/NN
to/TO
request/VB
services/VBZ
through/IN
a/DT
URL/NN
./.
====================
Because/IN
it/PRP
uses/VBZ
data/NNS
messages/NNS
in/IN
the/DT
form/NN
of/IN
JavaScript/NN
Object/JJ
Notation/NN
(/(
JSON/NN
)/)
,/,
which/WDT
is/VBZ
small/JJ
in/IN
size/NN
,/,
it/PRP
is/VBZ
mainly/RB
used/VBN
for/IN
mobile/JJ
services/VBZ
at/IN
present/JJ
[/(
11/CD
]/)
./.
====================
OAuth/DT
2.0/CD
uses/VBZ
Transport/NN
Layer/JJ
Security/NN
(/(
TLS/NNS
)/)
to/TO
give/VB
and/CC
take/VBP
authorization/NN
tokens/NNS
and/CC
messages/NNS
./.
====================
There/EX
are/VBP
four/CD
authorization/NN
methods/NNS
./.
====================
Because/IN
the/DT
authorization/NN
method/NN
differs/VBZ
by/IN
scenario/NN
,/,
load/NN
in/IN
a/DT
server/NN
should/MD
be/VB
considered/VBN
./.
====================
It/PRP
should/MD
support/VB
scalability/NN
for/IN
a/DT
large/JJ
service/JJ
./.
====================
In/IN
addition/NN
,/,
the/DT
service/NN
provider/NN
and/CC
authorization/NN
server/RB
are/VBP
completely/RB
separate/JJ
;/:
so/RB
,/,
server/RB
multiplexing/JJ
and/CC
authorization/NN
server/RB
multiplexing/JJ
are/VBP
possible/JJ
./.
====================
There/EX
are/VBP
four/CD
authorization/NN
methods/NNS
:/:
authorization/NN
code/VBP
grant/JJ
(/(
ACG/NN
)/)
,/,
implicit/VBP
grant/JJ
(/(
IG/NN
)/)
,/,
resource/NN
owner/JJ
password/NN
credentials/NNS
grant/JJ
(/(
ROPCG/NN
)/)
,/,
and/CC
client/JJ
credential/JJ
grant/JJ
(/(
CCG/NN
)/)
./.
====================
ACG/NN
and/CC
IG/NN
are/VBP
re-direction/NN
methods/NNS
and/CC
should/MD
interact/VB
with/IN
resource/NN
owners/NNS
and/CC
receive/JJ
requests/VBZ
./.
====================
ROPCG/NN
is/VBZ
an/DT
authorization/NN
method/NN
in/IN
which/WDT
a/DT
client/JJ
receives/VBZ
a/DT
resource/NN
owner/JJ
's/POS
authorization/NN
information/NN
directly/RB
and/CC
relays/VBZ
it/PRP
to/TO
the/DT
authorization/NN
server/RB
./.
====================
CCG/NN
can/MD
provide/VB
requests/NNS
only/RB
with/IN
an/DT
authorization/NN
token/NN
./.
====================
Complicated/JJ
methods/NNS
,/,
such/JJ
as/IN
ACG/NN
and/CC
IG/NN
,/,
are/VBP
not/RB
needed/VBN
in/IN
a/DT
database/NN
environment/NN
for/IN
analysis/NN
,/,
because/IN
the/DT
level/NN
of/IN
trust/JJ
between/IN
users/NNS
and/CC
providers/NNS
is/VBZ
high/JJ
./.
====================
In/IN
addition/NN
,/,
CCG/NN
can/MD
not/RB
be/VB
used/VBN
,/,
because/IN
resources/VBZ
have/VBP
to/TO
be/VB
used/VBN
./.
====================
Therefore/RB
,/,
ROPCG/NN
is/VBZ
the/DT
most/JJS
appropriate/JJ
method/NN
for/IN
IABio/NN
./.
====================
The/DT
IABio/NN
platform/NN
service/RB
can/MD
be/VB
applied/VBN
with/IN
medical/JJ
information/NN
security/NN
guidelines/NNS
;/:
can/MD
provide/VB
a/DT
portal/JJ
service/RB
;/:
and/CC
can/MD
collect/VB
and/CC
analyze/VB
databases/NNS
related/JJ
to/TO
IA/NN
./.
====================
To/TO
design/VB
the/DT
proposed/JJ
service/IN
model/NN
,/,
our/PRP$
study/NN
explains/VBZ
the/DT
analysis/NN
of/IN
requirements/NNS
,/,
the/DT
structure/NN
of/IN
the/DT
platform/NN
service/RB
,/,
the/DT
contents/NNS
of/IN
the/DT
service/NN
,/,
and/CC
the/DT
user/NN
authorization/NN
method/NN
./.
====================
Analysis/NN
of/IN
requirements/NNS
====================
It/PRP
is/VBZ
necessary/JJ
to/TO
analyze/VB
the/DT
complicated/VBN
requirements/NNS
of/IN
the/DT
system/NN
to/TO
design/VB
and/CC
develop/VBP
the/DT
IABio/NN
platform/NN
service/RB
./.
====================
Because/IN
security/NN
is/VBZ
very/RB
important/JJ
to/TO
a/DT
medical/JJ
information/NN
system/NN
,/,
it/PRP
requires/VBZ
user/NN
identification/NN
./.
====================
In/IN
addition/NN
,/,
the/DT
data/NNS
exchange/NN
method/NN
,/,
integrated/VBN
data/NNS
composition/NN
,/,
and/CC
services/VBZ
should/MD
be/VB
specified/VBN
./.
====================
User/NN
identification/NN
====================
It/PRP
is/VBZ
needed/VBN
to/TO
analyze/VB
patients/NNS
'/``
genomic/JJ
data/NNS
concerning/VBG
IA/NN
for/IN
treatment/NN
and/CC
prevention/NN
and/CC
to/TO
provide/VB
them/PRP
with/IN
customized/VBN
service/RB
./.
====================
To/TO
do/VBP
so/RB
,/,
an/DT
integrated/JJ
data/NNS
analysis/NN
system/NN
is/VBZ
required/VBN
and/CC
should/MD
work/NN
with/IN
all/DT
genomic/JJ
information/NN
./.
====================
Users/NNS
with/IN
access/RB
to/TO
IABio/NN
are/VBP
classified/VBN
into/IN
gene/NN
researcher/RB
,/,
protein/NN
researcher/RB
,/,
brain/NN
imaging/NN
researcher/RB
,/,
senior/JJ
researcher/RB
for/IN
integrated/JJ
work/NN
,/,
and/CC
server/RB
manager/VBP
./.
====================
Each/DT
manager/NN
has/VBZ
access/RB
to/TO
a/DT
patient/NN
's/POS
genome/NN
information/NN
according/VBG
to/TO
the/DT
Medical/JJ
Care/NN
Act/NN
,/,
but/CC
the/DT
researcher/JJ
is/VBZ
limited/JJ
to/TO
only/RB
'concerned/VBN
'/``
information/NN
and/CC
can/MD
not/RB
have/VB
access/RB
to/TO
other/JJ
information/NN
./.
====================
However/RB
,/,
all/DT
of/IN
the/DT
researchers/NNS
can/MD
have/VB
access/RB
to/TO
the/DT
risk/NN
outcome/NN
that/IN
is/VBZ
yielded/VBN
from/IN
the/DT
integrated/JJ
analysis/NN
of/IN
all/DT
genomic/JJ
information/NN
./.
====================
The/DT
integrated/JJ
analysis/NN
risk/NN
results/NNS
do/VBP
not/RB
include/VB
individual/JJ
patient/NN
information/NN
but/CC
are/VBP
considered/VBN
new/JJ
information/NN
and/CC
thus/RB
are/VBP
not/RB
against/IN
the/DT
Medical/JJ
Care/NN
Act/NN
./.
====================
Therefore/RB
,/,
each/DT
researcher/RB
can/MD
search/VB
,/,
enter/VBP
data/NNS
,/,
and/CC
modify/VB
genomic/JJ
data/NNS
he/VBP
manages/VBZ
and/CC
can/MD
search/VB
out/IN
integrated/VBN
analysis/NN
outcomes/VBZ
./.
====================
Standard-based/JJ
biological/JJ
data/NNS
exchange/VBP
====================
To/TO
subdivide/VB
access/VBP
from/IN
each/DT
researcher/RB
,/,
access/VBP
control/NN
is/VBZ
needed/VBN
or/CC
else/NN
the/DT
server/NN
manager/VBP
can/MD
not/RB
even/RB
read/VBD
the/DT
genomic/JJ
data/NNS
./.
====================
Therefore/RB
,/,
a/DT
server/NN
manager/VBP
can/MD
only/RB
control/NN
information/NN
that/IN
the/DT
genome/NN
manager/VBP
has/VBZ
access/RB
to/TO
./.
====================
To/TO
do/VBP
so/RB
,/,
the/DT
authorization/NN
server/RB
and/CC
IABio/NN
server/RB
have/VBP
to/TO
be/VB
separated/VBN
physically/RB
./.
====================
Medical/JJ
information/NN
standard-based/VBD
guidelines/NNS
and/CC
access/VBP
control/NN
are/VBP
necessary/JJ
for/IN
authorization/NN
and/CC
approval/JJ
./.
====================
Integrated/JJ
biological/JJ
data/NNS
platform/VBP
====================
Biological/JJ
data/NNS
(/(
gene/NN
,/,
protein/NN
,/,
and/CC
brain/NN
structure/NN
image/NN
)/)
have/VBP
different/JJ
identifier/NN
values/NNS
./.
====================
However/RB
,/,
if/IN
several/JJ
pieces/NNS
of/IN
genomic/JJ
data/NNS
for/IN
one/CD
patient/NN
have/VBP
more/RBR
than/IN
one/CD
identifier/NN
,/,
it/PRP
is/VBZ
against/IN
data/NNS
integrity/NN
,/,
because/IN
information/NN
for/IN
one/CD
patient/NN
is/VBZ
duplicated/VBN
./.
====================
In/IN
addition/NN
,/,
because/IN
genome/NN
information/NN
entered/VBD
by/IN
each/DT
data/NNS
manager/VBP
is/VBZ
created/VBN
in/IN
different/JJ
systems/NNS
,/,
an/DT
identification/NN
system/NN
is/VBZ
needed/VBN
./.
====================
Web/NN
portal/JJ
service/RB
====================
Access/RB
to/TO
an/DT
integrated/JJ
database/NN
requires/VBZ
an/DT
accessible/JJ
service/RB
and/CC
web/NN
portal/JJ
service/RB
in/IN
which/WDT
the/DT
authorization/NN
and/CC
approval/JJ
procedure/NN
has/VBZ
been/VBN
established/VBN
,/,
which/WDT
is/VBZ
necessary/JJ
to/TO
search/VB
data/NNS
related/JJ
to/TO
a/DT
genome/NN
./.
====================
Therefore/RB
,/,
it/PRP
is/VBZ
necessary/JJ
to/TO
provide/VB
an/DT
integrated/JJ
service/NN
using/VBG
a/DT
security/NN
system/NN
suitable/JJ
for/IN
medical/JJ
standards/NNS
./.
====================
Accordingly/RB
,/,
a/DT
web/NN
portal/JJ
is/VBZ
designed/VBN
using/VBG
OAuth/NN
2.0/CD
./.
====================
Provision/NN
of/IN
data/NNS
analysis/NN
output/RB
====================
IA/NN
risk/NN
factors/NNS
should/MD
be/VB
provided/VBN
through/IN
integrated/JJ
analysis/NN
based/VBN
on/IN
data/NNS
entered/VBD
by/IN
each/DT
researcher/RB
and/CC
user/NN
./.
====================
Integrated/JJ
information/NN
should/MD
be/VB
provided/VBN
for/IN
single/JJ
nucleotide/NN
polymorphisms/NNS
(/(
SNP/NN
)/)
and/CC
protein/NN
markers/NNS
related/JJ
to/TO
IA/NN
./.
====================
Also/RB
,/,
the/DT
accuracy/NN
of/IN
risk/NN
factors/NNS
should/MD
advance/VB
enough/IN
to/TO
utilize/VB
a/DT
diagnostic/JJ
index/NN
./.
====================
After/IN
risk/NN
factors/NNS
that/WDT
are/VBP
highly/RB
relevant/JJ
to/TO
IA/NN
are/VBP
determined/VBN
through/IN
the/DT
integrated/JJ
analysis/NN
of/IN
several/JJ
areas/NNS
in/IN
the/DT
genome/NN
,/,
a/DT
risk/NN
evaluation/NN
score/RB
for/IN
the/DT
respective/JJ
factor/NN
should/MD
be/VB
provided/VBN
./.
====================
To/TO
compose/VB
such/JJ
a/DT
sophisticated/JJ
system/NN
,/,
our/PRP$
study/NN
uses/VBZ
medical/JJ
standard/JJ
guidelines/NNS
in/IN
designing/VBG
the/DT
genome/NN
database/NN
platform/NN
./.
====================
IABio/NN
service/NN
architecture/NN
====================
Aiming/VBG
to/TO
provide/VB
a/DT
genome/NN
database/NN
platform/NN
for/IN
IA/NN
,/,
our/PRP$
study/NN
designs/VBZ
the/DT
IABio/NN
platform/NN
service/RB
structure/NN
in/IN
consideration/NN
of/IN
medical/JJ
standard/JJ
security/NN
and/CC
requirements/NNS
as/IN
shown/VBN
in/IN
Fig/NN
./.
====================
2/CD
./.
====================
By/IN
relevance/NN
to/TO
the/DT
genome/NN
,/,
the/DT
users/NNS
are/VBP
divided/VBN
into/IN
gene/NN
researcher/RB
,/,
protein/NN
researcher/RB
,/,
brain/NN
imaging/NN
researcher/RB
,/,
and/CC
senior/JJ
researcher/RB
./.
====================
Each/DT
user/NN
can/MD
operate/VB
and/CC
monitor/VB
accessible/JJ
data/NNS
by/IN
his/her/NN
authority/NN
./.
====================
In/IN
addition/NN
,/,
the/DT
users/NNS
can/MD
connect/VB
to/TO
it/PRP
through/IN
a/DT
smart/JJ
device/RB
or/CC
web/NN
service/NN
./.
====================
For/IN
users/NNS
to/TO
have/VB
access/RB
to/TO
IABio/NN
,/,
they/PRP
should/MD
be/VB
issued/VBN
authorization/NN
tokens/NNS
from/IN
the/DT
authorization/NN
server/RB
./.
====================
The/DT
authorization/NN
token/VBN
functions/NNS
to/TO
identify/VB
researchers/NNS
using/VBG
genome/NN
information/NN
and/CC
is/VBZ
physically/RB
separated/VBN
from/IN
the/DT
IABio/NN
platform/NN
./.
====================
When/WRB
using/VBG
such/JJ
an/DT
authorization/NN
token/NN
,/,
it/PRP
is/VBZ
possible/JJ
to/TO
access/VB
IABio/NN
./.
====================
When/WRB
an/DT
authorization/NN
token/VBN
is/VBZ
not/RB
valid/JJ
or/CC
when/WRB
a/DT
user/NN
is/VBZ
not/RB
registered/VBN
,/,
the/DT
token/NN
should/MD
be/VB
issued/VBN
or/CC
re-issued/JJ
by/IN
the/DT
authorization/NN
server/RB
./.
====================
Our/PRP$
study/NN
complies/VBZ
with/IN
IUA/NN
medical/JJ
standard/JJ
guidelines/NNS
for/IN
access/NN
,/,
uses/VBZ
OAuth/NN
2.0/CD
,/,
and/CC
composes/NNS
the/DT
security/NN
system/NN
./.
====================
IABio/NN
is/VBZ
accessible/JJ
through/IN
a/DT
web/NN
portal/JJ
./.
====================
Genome/DT
data/NNS
entered/VBD
by/IN
each/DT
researcher/RB
are/VBP
entered/VBN
in/IN
a/DT
database/NN
in/IN
an/DT
agreeable/JJ
format/IN
to/TO
master/JJ
patient/NN
index/NN
(/(
MPI/NN
)/)
structure/NN
./.
====================
Because/IN
gene/NN
,/,
protein/NN
,/,
and/CC
brain/NN
imaging/NN
data/NNS
are/VBP
all/DT
in/IN
different/JJ
data/NNS
formats/VBZ
,/,
a/DT
method/NN
is/VBZ
necessary/JJ
to/TO
integrate/VB
them/PRP
./.
====================
Therefore/RB
,/,
MPI/NN
is/VBZ
used/VBN
./.
====================
It/PRP
allows/VBZ
scalability/NN
in/IN
connection/NN
with/IN
different/JJ
clinical/JJ
data/NNS
./.
====================
MPI/NN
configures/VBZ
the/DT
data/NNS
format/VBP
in/IN
a/DT
way/NN
to/TO
identify/VB
them/PRP
,/,
develops/VBZ
them/PRP
into/IN
a/DT
hash-type/JJ
algorithm/NN
,/,
creates/VBZ
an/DT
identification/NN
system/NN
,/,
and/CC
maintains/VBZ
data/NNS
integrity/NN
./.
====================
In/IN
an/DT
MPI-based/JJ
identification/NN
system/NN
,/,
each/DT
manager/VBP
does/VBZ
not/RB
know/VB
the/DT
password/NN
structure/NN
./.
====================
Therefore/RB
,/,
researchers/NNS
can/MD
not/RB
have/VB
access/RB
to/TO
different/JJ
data/NNS
./.
====================
The/DT
security/NN
system/NN
of/IN
the/DT
proposed/JJ
IABio/NN
platform/NN
has/VBZ
pre-defined/VBN
password/NN
keys/NNS
with/IN
the/DT
authorization/NN
server/RB
and/CC
performs/NNS
the/DT
authorization/NN
and/CC
approval/JJ
procedure/NN
by/IN
the/DT
user/NN
./.
====================
The/DT
contents/NNS
of/IN
MPI/NN
are/VBP
not/RB
described/VBN
here/RB
,/,
because/IN
they/PRP
are/VBP
not/RB
part/NN
of/IN
the/DT
aim/NN
of/IN
this/DT
study/NN
./.
====================
Three/CD
analyses/NNS
are/VBP
performed/VBN
to/TO
provide/VB
services/NNS
from/IN
IABio/NN
./.
====================
The/DT
first/JJ
is/VBZ
proteomics/NNS
analysis/NN
./.
====================
Proteomics/NNS
is/VBZ
a/DT
study/NN
concerned/VBD
with/IN
the/DT
structure/NN
and/CC
analysis/NN
of/IN
proteins/NNS
occurring/VBG
in/IN
living/JJ
organisms/NNS
./.
====================
It/PRP
aims/VBZ
to/TO
analyze/VB
proteins/NNS
on/IN
a/DT
great/JJ
scale/NN
;/:
write/RB
a/DT
map/NN
of/IN
functional/JJ
interrelations/NNS
;/:
and/CC
demonstrate/VBP
a/DT
certain/JJ
protein/NN
and/CC
the/DT
gene/NN
that/WDT
creates/VBZ
it/PRP
through/IN
structural/JJ
analysis/NN
./.
====================
The/DT
second/JJ
analysis/NN
is/VBZ
IA/NN
risk/NN
factor/NN
analysis/NN
./.
====================
SNPs/NNS
and/CC
protein/NN
markers/NNS
related/JJ
to/TO
IA/NN
yield/VB
risk/NN
factors/NNS
for/IN
IA/NN
./.
====================
In/IN
addition/NN
,/,
it/PRP
analyzes/VBZ
clinical/JJ
data/NNS
,/,
such/JJ
as/IN
survey/RB
,/,
patient/NN
interview/NN
,/,
functional/JJ
magnetic/JJ
resonance/NN
imaging/VBG
,/,
and/CC
brain/NN
imaging/VBG
,/,
in/IN
addition/NN
to/TO
a/DT
genome/protein/JJ
index/NN
,/,
in/IN
integrated/JJ
manner/NN
,/,
finally/RB
creating/VBG
a/DT
diagnostic/JJ
index/NN
./.
====================
The/DT
third/JJ
analysis/NN
is/VBZ
risk/NN
evaluation/NN
analysis/NN
./.
====================
When/WRB
risk/NN
factors/NNS
highly/RB
relevant/JJ
to/TO
IA/NN
are/VBP
determined/VBN
by/IN
integrated/JJ
analysis/NN
of/IN
genome/NN
data/NNS
,/,
it/PRP
generates/VBZ
an/DT
algorithm/NN
to/TO
provide/VB
a/DT
risk/NN
evaluation/NN
score/RB
for/IN
the/DT
respective/JJ
factor/NN
./.
====================
In/IN
this/DT
study/NN
,/,
the/DT
contents/NNS
of/IN
genome/NN
analyses/NNS
are/VBP
not/RB
described/VBN
,/,
because/IN
they/PRP
are/VBP
separate/JJ
areas/NNS
of/IN
study/NN
./.
====================
Because/IN
IABio/NN
service/RB
model/NN
proposed/VBN
in/IN
our/PRP$
study/NN
can/MD
ensure/VB
safe/JJ
access/VBP
to/TO
information/NN
entered/VBD
by/IN
users/NNS
and/CC
can/MD
provide/VB
integrated/JJ
data/NNS
analysis/NN
service/VBP
./.
====================
It/PRP
can/MD
be/VB
applied/VBN
to/TO
several/JJ
platforms/NNS
as/IN
well/RB
as/IN
studies/NNS
related/JJ
to/TO
IA/NN
./.
====================
IABio/NN
service/NN
architecture/NN
====================
Fig/NN
./.
====================
3/CD
shows/VBZ
the/DT
authorization/NN
processing/NN
procedure/NN
of/IN
the/DT
token/NN
method/NN
and/CC
the/DT
service/NN
contents/NNS
that/IN
each/DT
user/NN
is/VBZ
provided/VBN
in/IN
the/DT
use/NN
case/NN
diagram/NN
./.
====================
Four/CD
actors/NNS
consist/VBP
of/IN
a/DT
researcher/JJ
,/,
database/NN
,/,
web/NN
portal/JJ
,/,
and/CC
authorization/NN
server/RB
./.
====================
A/DT
researcher/JJ
accesses/VBZ
the/DT
authorization/NN
system/NN
to/TO
have/VB
access/RB
to/TO
the/DT
IABio/NN
platform/NN
and/CC
requests/VBZ
an/DT
access/NN
token/VBN
./.
====================
The/DT
authorization/NN
server/RB
confirms/VBZ
the/DT
legitimacy/NN
of/IN
the/DT
access/NN
by/IN
the/DT
user/NN
and/CC
issues/NNS
the/DT
right/JJ
access/VBP
token/VBN
for/IN
his/her/JJ
authority/NN
./.
====================
Then/RB
,/,
the/DT
researcher/NN
acquires/VBZ
the/DT
access/NN
token/NN
./.
====================
The/DT
researcher/JJ
proceeds/VBZ
to/TO
access/VB
the/DT
IABio/NN
platform/NN
through/IN
a/DT
portal/JJ
./.
====================
The/DT
web/NN
portal/JJ
and/CC
database/NN
identify/VBP
the/DT
access/NN
token/NN
./.
====================
When/WRB
the/DT
login/NN
is/VBZ
done/VBN
properly/RB
,/,
the/DT
user/NN
can/MD
input/VB
and/CC
output/NN
data/NNS
./.
====================
Data/NNS
can/MD
be/VB
entered/VBN
according/VBG
to/TO
information/NN
related/JJ
to/TO
a/DT
concerned/JJ
genome/NN
./.
====================
Genome/DT
input/NN
data/NNS
are/VBP
analyzed/VBN
,/,
and/CC
the/DT
analyzed/VBN
information/NN
is/VBZ
saved/VBN
./.
====================
The/DT
researcher/JJ
requests/VBZ
data/NNS
output/VBP
to/TO
monitor/VB
the/DT
analysis/NN
results/VBZ
and/CC
related/JJ
data/NNS
./.
====================
Token/RB
authorization/NN
contents/NNS
are/VBP
analyzed/VBN
for/IN
a/DT
second/JJ
time/NN
to/TO
check/VB
if/IN
the/DT
researcher/JJ
is/VBZ
legitimate/JJ
for/IN
data/NNS
confirmation/NN
before/IN
the/DT
analysis/NN
results/VBZ
and/CC
entered/VBD
information/NN
are/VBP
retrieved/VBN
./.
====================
OAuth/DT
2.0-based/VBN
authorization/NN
model/NN
====================
In/IN
this/DT
study/NN
,/,
the/DT
IUA/NN
guideline/NN
[/(
5/CD
]/)
and/CC
OAuth/NN
2.0/CD
[/(
6/CD
]/)
are/VBP
used/VBN
to/TO
design/VB
and/CC
realize/VBP
IABio/NN
./.
====================
Researchers/NNS
should/MD
obtain/VB
access/VBP
authorization/NN
to/TO
use/VB
IABio/NN
and/CC
the/DT
concerned/JJ
data/NNS
./.
====================
The/DT
server/NN
manager/VBP
who/WP
controls/VBZ
the/DT
authorization/NN
server/RB
should/MD
not/RB
have/VB
access/RB
to/TO
the/DT
database/NN
in/IN
which/WDT
patient/NN
information/NN
is/VBZ
saved/VBN
./.
====================
Therefore/RB
,/,
the/DT
IABio/NN
server/RB
should/MD
be/VB
physically/RB
separated/VBN
from/IN
the/DT
authorization/NN
server/RB
and/CC
provide/VBP
only/RB
authorization/NN
and/CC
authority/NN
./.
====================
This/DT
kind/NN
of/IN
environment/NN
is/VBZ
suitable/JJ
for/IN
the/DT
IUA/NN
guideline/NN
./.
====================
In/IN
this/DT
study/NN
,/,
the/DT
authorization/NN
method/NN
uses/VBZ
the/DT
OAuth/NN
2.0-based/VBN
ROPCG/NN
method/NN
and/CC
is/VBZ
designed/VBN
in/IN
a/DT
communication/NN
diagram/NN
,/,
as/IN
in/IN
Fig/NN
./.
====================
4/CD
./.
====================
Our/PRP$
study/NN
proposes/VBZ
an/DT
authorization/NN
method/NN
based/VBN
on/IN
the/DT
2-step/JJ
access/VBP
authorization/NN
of/IN
IABio/NN
,/,
along/IN
with/IN
resource/NN
owner/JJ
server/RB
(/(
web/NN
portal/JJ
)/)
authorization/NN
./.
====================
Each/DT
researcher/JJ
(/(
client/JJ
)/)
should/MD
be/VB
assigned/VBN
an/DT
authorization/NN
token/VBN
from/IN
the/DT
authorization/NN
server/RB
to/TO
get/VB
access/VBP
to/TO
the/DT
portal/JJ
./.
====================
After/IN
obtaining/VBG
the/DT
authorization/NN
token/VBN
,/,
the/DT
researcher/JJ
has/VBZ
access/RB
to/TO
the/DT
portal/JJ
and/CC
proceeds/VBZ
with/IN
the/DT
first/JJ
authorization/NN
./.
====================
Next/RB
,/,
the/DT
researcher/NN
gets/NNS
the/DT
second/JJ
authorization/NN
in/IN
IABio/NN
to/TO
use/VB
the/DT
service/NN
./.
====================
Because/IN
security/NN
authorization/NN
is/VBZ
strictly/RB
designed/VBN
in/IN
double/JJ
walls/NNS
,/,
it/PRP
can/MD
avoid/VB
weaknesses/NNS
to/TO
phishing/VBG
scams/NNS
and/CC
impersonation/NN
attacks/NNS
./.
====================
The/DT
first/JJ
step/NN
of/IN
the/DT
authorization/NN
procedure/NN
is/VBZ
to/TO
check/VB
if/IN
it/PRP
is/VBZ
possible/JJ
to/TO
identify/VB
users/NNS
'/``
personal/JJ
information/NN
./.
====================
The/DT
second/JJ
authorization/NN
step/NN
proceeds/VBZ
with/IN
authorization/NN
for/IN
database/NN
access/VBP
one/CD
more/RBR
time/NN
./.
====================
Our/PRP$
study/NN
uses/VBZ
this/DT
2-step/JJ
authorization/NN
in/IN
designing/VBG
and/CC
developing/VBG
IABio/NN
./.
====================
System/NN
environment/NN
====================
Fig/NN
./.
====================
5/CD
shows/VBZ
the/DT
system/NN
environment/NN
in/IN
which/WDT
the/DT
IABio/NN
system/NN
is/VBZ
composed/VBN
with/IN
OAuth/NN
2.0/CD
of/IN
a/DT
medical/JJ
information/NN
standard/JJ
environment/NN
./.
====================
The/DT
system/NN
environment/NN
has/VBZ
the/DT
structure/NN
of/IN
a/DT
hardware/JJ
and/CC
development/NN
environment/NN
./.
====================
Two/CD
servers/NNS
are/VBP
used/VBN
:/:
IABio/NN
server/RB
and/CC
authorization/NN
server/RB
./.
====================
HP/NN
ProLiant/JJ
Micro/NN
Server/NN
Gen8/NN
is/VBZ
used/VBN
to/TO
design/VB
the/DT
IABio/NN
database/NN
,/,
and/CC
it/PRP
consists/VBZ
of/IN
1TB/NN
SSD/NN
,/,
2TB/NN
HDD/NN
,/,
and/CC
12GB/NN
RAM/NN
./.
====================
To/TO
compose/VB
the/DT
development/NN
environment/NN
,/,
Apache/DT
2.2/CD
is/VBZ
used/VBN
as/IN
server/RB
software/JJ
to/TO
configure/VB
the/DT
Tomcat/NN
Server/NN
./.
====================
For/IN
the/DT
web/NN
service/RB
,/,
PHP/NN
5.2/CD
is/VBZ
used/VBN
to/TO
supplement/VB
the/DT
functions/NNS
of/IN
existing/VBG
HTTP/NN
language/NN
./.
====================
MySQL/NN
5.1/CD
is/VBZ
used/VBN
to/TO
compose/VB
the/DT
Tomcat/NN
server/RB
and/CC
PHP/NN
,/,
which/WDT
can/MD
interwork/VB
with/IN
the/DT
database/NN
./.
====================
APM/NN
(/(
Apache/DT
,/,
PHP/NN
,/,
MySQL/NN
)/)
is/VBZ
mutually/RB
complementary/JJ
and/CC
flexible/JJ
for/IN
interworking/VBG
./.
====================
Furthermore/RB
,/,
it/PRP
is/VBZ
compatible/JJ
with/IN
all/DT
operating/VBG
systems/NNS
,/,
such/JJ
as/IN
Unix/JJ
,/,
Linux/JJ
,/,
and/CC
Windows/VBZ
./.
====================
The/DT
authorization/NN
server/RB
uses/VBZ
Naver/NN
application/NN
programming/VBG
interface/NN
(/(
API/NN
)/)
,/,
which/WDT
supports/VBZ
OAuth/NN
2.0/CD
[/(
12/CD
]/)
./.
====================
Since/IN
Naver/NN
API/NN
provides/VBZ
a/DT
security/NN
server/RB
in/IN
itself/PRP
,/,
it/PRP
is/VBZ
cost-effective/JJ
./.
====================
In/IN
addition/NN
,/,
it/PRP
is/VBZ
possible/JJ
to/TO
customize/VB
so/RB
as/IN
to/TO
receive/JJ
an/DT
authorization/NN
token/VBN
by/IN
using/VBG
Naver/NN
ID/NN
./.
====================
Currently/RB
,/,
most/JJS
domestic/JJ
web/NN
service/NN
providers/NNS
related/JJ
to/TO
authorization/NN
use/NN
OAuth/NN
2.0/CD
of/IN
Naver/NN
API/NN
./.
====================
Therefore/RB
,/,
it/PRP
can/MD
ensure/VB
security/NN
./.
====================
JSON/NN
method/NN
is/VBZ
employed/VBN
for/IN
the/DT
exchange/NN
of/IN
messages/NNS
between/IN
a/DT
portal/JJ
and/CC
database/NN
server/RB
and/CC
authorization/NN
server/RB
./.
====================
The/DT
JSON/NN
method/NN
enables/VBZ
message/NN
exchange/NN
with/IN
shorter/JJR
codes/VBZ
than/IN
the/DT
existing/VBG
Extensible/JJ
Markup/NN
Language/NN
(/(
XML/NN
)/)
method/NN
./.
====================
Therefore/RB
,/,
it/PRP
is/VBZ
faster/JJR
in/IN
speed/JJ
and/CC
can/MD
reduce/VB
load/NN
./.
====================
For/IN
security/NN
protocol/NN
,/,
IUA/NN
guidelines/NNS
and/CC
OAuth/NN
2.0/CD
are/VBP
used/VBN
./.
====================
PHP/NN
2.2/CD
is/VBZ
used/VBN
to/TO
realize/VB
OAuth/NN
2.0/CD
./.
====================
The/DT
JSON/NN
method/NN
can/MD
transmit/VB
authorization/NN
tokens/NNS
and/CC
protect/VB
users/VBZ
'/``
personal/JJ
information/NN
./.
====================
The/DT
database/NN
module/NN
is/VBZ
structured/JJ
to/TO
have/VB
access/RB
to/TO
genome/NN
data/NNS
./.
====================
The/DT
authorization/NN
token/NN
method/NN
should/MD
be/VB
used/VBN
to/TO
have/VB
access/RB
to/TO
a/DT
database/NN
module/NN
./.
====================
The/DT
Advanced/JJ
Encryption/NN
Standard/NN
(/(
AES/NNS
)/)
256/CD
algorithm/NN
is/VBZ
used/VBN
to/TO
enhance/VB
the/DT
level/NN
of/IN
security/NN
./.
====================
AES/NNS
256/CD
is/VBZ
a/DT
symmetric/JJ
key/JJ
algorithm/NN
that/DT
supports/VBZ
block/VBP
passwords/NNS
./.
====================
AES/NNS
256/CD
is/VBZ
the/DT
most/JJS
reliable/JJ
symmetric/JJ
key/JJ
algorithm/NN
among/IN
any/DT
developed/VBD
thus/RB
far/RB
./.
====================
Its/PRP$
method/NN
uses/VBZ
key/JJ
values/NNS
used/VBN
between/IN
a/DT
user/NN
and/CC
service/NN
./.
====================
A/DT
user/NN
can/MD
access/VB
the/DT
web/NN
portal/JJ
and/CC
database/NN
without/IN
concerned/VBD
keys/NNS
./.
====================
PHP/NN
2.2/CD
is/VBZ
used/VBN
for/IN
the/DT
module/NN
to/TO
have/VB
access/RB
to/TO
and/CC
operate/VB
IABio/NN
./.
====================
In/IN
addition/NN
,/,
MPI/NN
is/VBZ
used/VBN
to/TO
ensure/VB
the/DT
integrity/NN
of/IN
the/DT
genome/NN
database/NN
./.
====================
It/PRP
can/MD
support/VB
interworking/JJ
between/IN
data/NNS
./.
====================
Therefore/RB
,/,
data/NNS
integration/NN
is/VBZ
possible/JJ
./.
====================
Furthermore/RB
,/,
because/IN
MPI/NN
uses/VBZ
Hash/NN
256/CD
,/,
each/DT
user/NN
can/MD
confirm/VB
which/WDT
data/NNS
are/VBP
interworked/VBN
./.
====================
The/DT
Bio-Marker/NN
database/NN
is/VBZ
composed/VBN
so/RB
as/IN
to/TO
receive/JJ
the/DT
entry/NN
of/IN
gene/NN
data/NNS
,/,
protein/NN
data/NNS
,/,
and/CC
brain/NN
imaging/NN
data/NNS
./.
====================
Security/NN
evaluation/NN
====================
OAuth/DT
2.0/CD
has/VBZ
a/DT
weakness/JJ
for/IN
vulnerable/JJ
replay/VBP
attacks/NNS
./.
====================
In/IN
this/DT
study/NN
,/,
a/DT
replay/NN
attack/NN
can/MD
solve/VB
problems/NNS
by/IN
using/VBG
the/DT
2-step/JJ
access/VBP
authorization/NN
./.
====================
Replay/NN
attack/NN
and/CC
defense/NN
scenarios/NNS
are/VBP
shown/VBN
in/IN
Fig/NN
./.
====================
6/CD
./.
====================
An/DT
attacker/NN
is/VBZ
disguised/VBN
as/IN
a/DT
client/JJ
to/TO
obtain/VB
an/DT
EC1/NN
key/JJ
(/(
with/IN
access/RB
token/VBN
)/)
when/WRB
passed/VBN
during/IN
the/DT
communication/NN
between/IN
the/DT
authorization/NN
server/RB
and/CC
client/JJ
./.
====================
The/DT
attacker/NN
,/,
disguised/VBD
as/IN
a/DT
client/JJ
,/,
attempts/NNS
to/TO
perform/VB
a/DT
replay/NN
attack/NN
obtained/VBN
using/VBG
the/DT
access/NN
token/VBN
./.
====================
In/IN
this/DT
case/NN
,/,
the/DT
attacker/NN
has/VBZ
access/RB
to/TO
the/DT
web/NN
portal/JJ
using/VBG
the/DT
EC1/NN
key/JJ
(/(
with/IN
access/NN
token/VBN
)/)
shared/VBN
with/IN
the/DT
authentication/NN
server/RB
./.
====================
However/RB
,/,
the/DT
EC2/NN
key/JJ
is/VBZ
needed/VBN
to/TO
access/VB
IABio/NN
database/NN
./.
====================
An/DT
attacker/NN
who/WP
does/VBZ
not/RB
have/VB
the/DT
EC2/NN
key/JJ
can/MD
not/RB
access/VB
the/DT
data/NNS
,/,
because/IN
the/DT
attacker/NN
can/MD
not/RB
analyze/VB
contents/NNS
in/IN
the/DT
access/NN
token/VBN
of/IN
EC2/NN
./.
====================
Thus/RB
,/,
an/DT
attacker/NN
can/MD
not/RB
access/VB
the/DT
IABio/NN
database/NN
,/,
because/IN
the/DT
attacker/NN
does/VBZ
not/RB
have/VB
the/DT
EC2/NN
key/JJ
./.
====================
EC1/NN
and/CC
EC2/NN
can/MD
be/VB
obtained/VBN
only/RB
from/IN
the/DT
pre-consultation/NN
process/NN
./.
====================
Implementation/NN
screen/NN
====================
The/DT
IABio/NN
platform/NN
uses/VBZ
the/DT
authorization/NN
server/RB
provided/VBD
in/IN
Naver/NN
API/NN
[/(
12/CD
]/)
./.
====================
Therefore/RB
,/,
it/PRP
can/MD
acquire/VB
an/DT
authorization/NN
token/VBN
in/IN
Naver/NN
and/CC
can/MD
have/VB
access/RB
to/TO
the/DT
portal/JJ
by/IN
using/VBG
it/PRP
./.
====================
To/TO
access/VB
the/DT
authorization/NN
server/RB
,/,
only/RB
a/DT
pre-authorized/JJ
Naver/NN
ID/NN
can/MD
be/VB
used/VBN
./.
====================
Therefore/RB
,/,
a/DT
token/NN
can/MD
be/VB
issued/VBN
or/CC
re-issued/JJ
only/RB
when/WRB
having/VBG
client/NN
information/NN
./.
====================
The/DT
left/NN
side/JJ
of/IN
Fig/NN
./.
====================
7/CD
shows/VBZ
the/DT
page/NN
to/TO
access/VB
the/DT
web/NN
portal/JJ
,/,
and/CC
the/DT
right/JJ
side/JJ
is/VBZ
the/DT
page/NN
to/TO
receive/JJ
authorization/NN
tokens/NNS
through/IN
Naver/NN
./.
====================
As/IN
seen/VBN
in/IN
Fig/NN
./.
====================
8/CD
,/,
login/NN
is/VBZ
done/VBN
to/TO
the/DT
authorization/NN
server/RB
with/IN
client/JJ
information/NN
./.
====================
Then/RB
,/,
it/PRP
is/VBZ
possible/JJ
to/TO
have/VB
access/RB
to/TO
the/DT
web/NN
portal/JJ
of/IN
IABio/NN
./.
====================
The/DT
right/JJ
side/JJ
of/IN
Fig/NN
./.
====================
8/CD
shows/VBZ
the/DT
contents/NNS
of/IN
personal/JJ
information/NN
and/CC
the/DT
authorization/NN
token/NN
received/VBD
from/IN
Naver/NN
./.
====================
The/DT
authorization/NN
token/NN
is/VBZ
transmitted/VBN
in/IN
the/DT
encryption/NN
of/IN
AES/NNS
256/CD
./.
====================
The/DT
contents/NNS
are/VBP
those/DT
of/IN
decoded/VBN
authorization/NN
tokens/NNS
./.
====================
Figs/NNS
./.
====================
9/CD
and/CC
10/CD
are/VBP
output/RB
results/NNS
made/VBD
by/IN
query/RB
from/IN
the/DT
data/NNS
saved/VBD
in/IN
the/DT
genome/NN
database/NN
./.
====================
It/PRP
is/VBZ
a/DT
screenshot/NN
of/IN
sample/JJ
data/NNS
,/,
not/RB
actual/JJ
clinical/JJ
data/NNS
./.
====================
Actual/JJ
data/NNS
can/MD
not/RB
be/VB
printed/VBN
out/RP
due/JJ
to/TO
the/DT
Medical/JJ
Care/NN
Act/NN
./.
====================
Fig/NN
./.
====================
9/CD
shows/VBZ
the/DT
screen/NN
that/DT
confirms/VBZ
the/DT
patient/NN
's/POS
basic/JJ
information/NN
./.
====================
Only/RB
personnel/NN
who/WP
are/VBP
authorized/VBN
for/IN
access/NN
to/TO
it/PRP
can/MD
read/VB
it/PRP
./.
====================
Fig/NN
./.
====================
10/CD
is/VBZ
a/DT
screenshot/NN
that/DT
confirms/VBZ
protein/NN
data/NNS
./.
====================
Only/RB
the/DT
personnel/NN
who/WP
are/VBP
authorized/VBN
for/IN
access/NN
to/TO
protein/NN
data/NNS
can/MD
read/VB
it/PRP
./.
====================
IA/NN
is/VBZ
a/DT
kind/JJ
of/IN
illness/NN
in/IN
which/WDT
the/DT
occurrence/NN
increases/VBZ
along/IN
with/IN
the/DT
development/NN
of/IN
IT/NN
technology/NN
./.
====================
Although/IN
it/PRP
is/VBZ
urgent/JJ
to/TO
have/VB
an/DT
analysis/NN
database/NN
of/IN
IA/NN
,/,
it/PRP
is/VBZ
not/RB
sufficient/JJ
now/RB
./.
====================
Because/IN
the/DT
database/NN
needed/VBD
to/TO
analyze/VB
medical/JJ
information/NN
handles/NNS
very/RB
sensitive/JJ
personal/JJ
data/NNS
,/,
security/NN
is/VBZ
very/RB
important/JJ
./.
====================
Our/PRP$
study/NN
proposed/VBD
the/DT
IABio/NN
platform/NN
service/NN
using/VBG
OAuth/NN
in/IN
a/DT
medical/JJ
information/NN
standardbased/VBD
environment/NN
./.
====================
The/DT
proposed/JJ
IABio/NN
uses/VBZ
IUA/NN
as/IN
a/DT
medical/JJ
standard/JJ
guideline/NN
and/CC
complies/NNS
with/IN
medical/JJ
information/NN
standards/VBZ
./.
====================
Also/RB
,/,
it/PRP
uses/VBZ
OAuth/NN
2.0/CD
,/,
which/WDT
is/VBZ
an/DT
access/NN
control/NN
technology/NN
./.
====================
To/TO
realize/VB
IABio/NN
,/,
it/PRP
is/VBZ
necessary/JJ
to/TO
analyze/VB
the/DT
complicated/VBN
requirements/NNS
of/IN
a/DT
medical/JJ
information/NN
system/NN
and/CC
to/TO
design/VB
the/DT
system/NN
from/IN
the/DT
perspective/JJ
of/IN
security/NN
./.
====================
In/IN
addition/NN
,/,
our/PRP$
study/NN
developed/VBD
a/DT
prototype/NN
IABio/NN
system/NN
and/CC
tested/VBN
if/IN
it/PRP
could/MD
be/VB
applied/VBN
with/IN
a/DT
security/NN
system/NN
./.
====================
As/IN
a/DT
result/NN
,/,
it/PRP
was/VBD
found/VBN
that/IN
each/DT
user/NN
had/VBD
a/DT
different/JJ
environment/NN
in/IN
which/WDT
the/DT
researcher/JJ
needed/VBD
to/TO
access/VB
a/DT
database/NN
./.
====================
Therefore/RB
,/,
it/PRP
is/VBZ
expected/VBN
that/DT
the/DT
proposed/JJ
IABio/NN
can/MD
be/VB
actively/RB
used/VBN
for/IN
studies/NNS
of/IN
IA/NN
./.
====================
As/IN
follow-up/JJ
research/NN
,/,
solutions/NNS
to/TO
phishing/VBG
scams/NNS
and/CC
re-use/VBP
attack/NN
,/,
to/TO
which/WDT
OAuth/NN
2.0/CD
is/VBZ
vulnerable/JJ
,/,
will/MD
be/VB
examined/VBN
./.
====================
Also/RB
,/,
an/DT
index/NN
searching/VBG
method/NN
will/MD
be/VB
studied/VBN
to/TO
quickly/RB
search/VBP
genome/NN
information/NN
related/JJ
to/TO
IA/NN
./.
====================
Internet/RB
user/NN
authentication/NN
actor/NN
diagram/NN
[/(
6/CD
]/)
./.
====================
Internet/RB
Addiction/NN
Bioinformatics/NNS
(/(
IABio/NN
)/)
service/VBP
model/NN
./.
====================
User/NN
case/NN
diagram/NN
of/IN
Internet/NN
Addiction/NN
Bioinformatics/NNS
(/(
IABio/NN
)/)
service/VBP
./.
====================
Communication/NN
diagram/NN
of/IN
authentication/NN
method/NN
with/IN
resource/NN
owner/JJ
password/NN
credentials/NNS
grant/JJ
[/(
6/CD
]/)
./.
====================
IABio/NN
,/,
Internet/NN
Addiction/NN
Bioinformatics/NNS
./.
====================
Internet/RB
Addiction/NN
Bioinformatics/NNS
(/(
IABio/NN
)/)
system/NN
environment/NN
./.
====================
MPI/NN
,/,
master/JJ
patient/NN
index/NN
;/:
JSON/NN
,/,
JavaScript/NN
Object/JJ
Notation/NN
;/:
API/NN
,/,
application/NN
programming/VBG
interface/NN
./.
====================
Replay/NN
attack/NN
scenario/NN
and/CC
defense/NN
./.
====================
IABioDB/NN
,/,
Internet/NN
Addiction/NN
Bioinformatics/NNS
database/NN
./.
====================
Authorization/NN
server/RB
page/NN
(/(
left/NN
and/CC
right/JJ
images/VBZ
indicate/VBP
web/NN
portal/JJ
login/NN
page/NN
and/CC
Naver/NN
login/NN
page/NN
for/IN
access/RB
token/VBN
,/,
respectively/RB
)/)
[/(
12/CD
]/)
./.
====================
IABio/NN
DB/NN
,/,
Internet/NN
Addiction/NN
Bioinformatics/NNS
database/NN
./.
====================
IABioDB/NN
web/NN
portal/JJ
(/(
left/NN
and/CC
right/JJ
images/VBZ
indicate/VBP
Naver/RB
login/NN
page/NN
and/CC
IABioDB/NN
web/NN
portal/JJ
access/VBP
,/,
respectively/RB
)/)
[/(
12/CD
]/)
./.
====================
Patient/JJ
information/NN
(/(
sample/NN
)/)
./.
====================
Protein/NN
data/NNS
(/(
sample/NN
)/)
./.
====================
